Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)
CUSIP: 007002108
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, par value $0.0001
- Shares outstanding
- 9,599,852
- Total 13F shares
- 21,191,598
- Share change
- +844,475
- Total reported value
- $218,012,000
- Price per share
- $10.29
- Number of holders
- 60
- Value change
- +$7,951,899
- Number of buys
- 38
- Number of sells
- 22
Quarterly Holders Quick Answers
What is CUSIP 007002108?
CUSIP 007002108 identifies ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 007002108:
Top shareholders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
75%
|
7,232,856
|
$94,606,000 | — | 31 Mar 2021 | |
| Avidity Partners Management LP |
13F
|
Company |
23%
|
2,230,000
|
$29,168,000 | — | 31 Mar 2021 | |
| Abingworth LLP |
13F
|
Company |
17%
|
1,615,385
|
$20,968,000 | — | 31 Mar 2021 | |
| Consonance Capital Management LP |
13F
|
Company |
13%
|
1,216,860
|
$15,917,000 | — | 31 Mar 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
11%
|
1,048,100
|
$13,709,000 | — | 31 Mar 2021 | |
| VR Adviser, LLC |
13F
|
Company |
10%
|
1,000,000
|
$13,080,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.4%
|
807,988
|
$10,569,000 | — | 31 Mar 2021 | |
| Johnson & Johnson Innovation - JJDC, Inc. |
13F
|
Company |
7.6%
|
728,944
|
$9,535,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.1%
|
489,628
|
$6,404,000 | — | 31 Mar 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
5.1%
|
488,000
|
$6,383,000 | — | 31 Mar 2021 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
4.4%
|
425,000
|
$5,559,000 | — | 31 Mar 2021 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
4.1%
|
395,875
|
$5,178,000 | — | 31 Mar 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
4%
|
385,077
|
$5,037,000 | — | 31 Mar 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
3.6%
|
341,269
|
$4,464,000 | — | 31 Mar 2021 | |
| Granite Point Capital Management, L.P. |
13F
|
Company |
2.5%
|
240,000
|
$3,139,000 | — | 31 Mar 2021 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
1.9%
|
181,626
|
$2,375,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.9%
|
180,041
|
$2,355,000 | — | 31 Mar 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
1.5%
|
142,289
|
$1,861,000 | — | 31 Mar 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.4%
|
135,094
|
$1,768,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
119,315
|
$1,560,000 | — | 31 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.1%
|
102,444
|
$1,340,000 | — | 31 Mar 2021 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1%
|
100,000
|
$1,308,000 | — | 31 Mar 2021 | |
| J. Goldman & Co LP |
13F
|
Company |
1%
|
96,046
|
$1,256,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.9%
|
86,292
|
$1,129,000 | — | 31 Mar 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.8%
|
76,381
|
$999,000 | — | 31 Mar 2021 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.75%
|
71,687
|
$938,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.48%
|
45,755
|
$598,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.45%
|
42,803
|
$560,000 | — | 31 Mar 2021 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.43%
|
41,421
|
$542,000 | — | 31 Mar 2021 | |
| Maven Securities LTD |
13F
|
Company |
0.39%
|
36,989
|
$489,000 | — | 31 Mar 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.34%
|
32,486
|
$425,000 | — | 31 Mar 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.29%
|
27,497
|
$360,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.3%
|
28,422
|
$355,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.27%
|
25,983
|
$340,000 | — | 31 Mar 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
24,284
|
$318,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.21%
|
20,100
|
$263,000 | — | 31 Mar 2021 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.19%
|
18,200
|
$238,000 | — | 31 Mar 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.44%
|
42,239
|
$230,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.16%
|
15,005
|
$196,000 | — | 31 Mar 2021 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.14%
|
13,567
|
$177,000 | — | 31 Mar 2021 | |
| Golden State Equity Partners |
13F
|
Company |
0.14%
|
13,145
|
$172,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.12%
|
11,688
|
$153,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.11%
|
10,510
|
$137,000 | — | 31 Mar 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
2,477
|
$32,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
1,693
|
$22,000 | — | 31 Mar 2021 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
914
|
$12,000 | — | 31 Mar 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
784
|
$11,000 | — | 31 Mar 2021 | |
| Penserra Capital Management LLC |
13F
|
Company |
0.01%
|
680
|
$8,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
476
|
$6,000 | — | 31 Mar 2021 | |
| FIFTH THIRD BANCORP |
13F
|
Company |
0%
|
142
|
$2,000 | — | 31 Mar 2021 |
Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q2 2021
As of 30 Jun 2021,
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,191,598 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Avidity Partners Management LP, Abingworth LLP, BlackRock Inc., Point72 Asset Management, L.P., VANGUARD GROUP INC, Consonance Capital Management LP, Johnson & Johnson Innovation - JJDC, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., and Ally Bridge Group (NY) LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
50
Q2 2021 holders
60
Holder diff
10
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.